Ticker Details
Replimune Group, Inc.
IPO Date:	July 16, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$932.63M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.60 | 3.89%
Avg Daily Range (30 D):	$0.50 | 6.93%
Avg Daily Range (90 D):	$0.47 | 8.53%

Institutional Daily Volume
Avg Daily Volume:	1.03M
Avg Daily Volume (30 D):	4.94M
Avg Daily Volume (90 D):	5.6M

Trade Size
Avg Trade Size (Sh.):	113
Avg Trade Size (Sh.) (30 D):	113
Avg Trade Size (Sh.) (90 D):	155

Institutional Trades
Total Institutional Trades:	2,452
Avg Institutional Trade:	$1.74M
Avg Institutional Trade (30 D):	$2.5M
Avg Institutional Trade (90 D):	$1.68M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.81M
Avg Closing Trade (30 D):	$3.64M
Avg Closing Trade (90 D):	$2.14M
Avg Closing Volume:	140.57K

News

May 18, 2026 @ 1:49 AM REPL Investors Have Opportunity to Join Replimune ... Source: Schall Law Firm

Apr 21, 2026 @ 8:14 AM Oncolytic Virus Immunotherapy Market Landscape Rep... Source: Researchandmarkets.Com

Apr 10, 2026 @ 9:02 PM Replimune Receives Complete Response Letter from t... Source: Replimune Group, Inc.

Jan 23, 2026 @ 10:52 AM Oncolytic Virotherapy Market - Global Industry Siz... Source: Researchandmarkets.Com

Nov 7, 2025 @ 9:45 PM Replimune Presents Late-Breaking Abstract and Addi... Source: Replimune Group, Inc.

Financials
	TTM	Q4 2026	FY 2026
Basic EPS	$-3.38	$-.76	$-3.38
Diluted EPS	$-3.38	$-.76	$-3.38
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-313.94M	$-73.22M	$-313.94M
Operating Income / Loss	$-319.92M	$-73.34M	$-319.92M
Cost of Revenue
Net Cash Flow	$97.91M	$86.07M	$97.91M
PE Ratio

Splits
Dec 01, 2010	15:1